Treatment Requires Understanding the "Why"

Researchers argue one cure won’t fit amyotrophic lateral sclerosis, so they’re changing how we fight the disease. By focusing on upper motor neurons in the brain and a drug called NU-9, they aim to slow degeneration and uncover new targets and biomarkers. This mechanism-focused path could speed smarter trials for people living with amyotrophic lateral sclerosis.